· Venture Capital Tracker · investment-strategies · 2 min read
Hopscotch Primary Care's $53M Series D: 8VC Doubles Down on Rural Clinics
8VC and Town Hall Ventures led Hopscotch’s $53M Series D (Aug 18, 2026). Tech-enabled primary care for 15,000+ rural patients across the Southeast — same-day access without replacing the clinician.
Hopscotch Primary Care raised $53 million Series D announced August 18, 2026, led by 8VC and Town Hall Ventures. The company runs tech-enabled primary care clinics for rural patients — not a consumer wellness app. Company: 15,000+ patients, 10+ locations, densest in rural Western North Carolina.
Deal snapshot
- $53M Series D
- Leads: 8VC, Town Hall Ventures
- Existing: aMoon, Citi Impact Fund, Alumni Ventures, K2 HealthVentures
- New: Autism Impact Fund, John Doerr, Dr. Richard Merkin, Leon Levine Foundation
- Use of proceeds: deepen Southeast access, new rural markets, scale tech-powered ops
- Profile: Hopscotch Primary Care
Who uses the product — and why
Patients in rural communities who otherwise face long waits and thin clinic coverage. Care teams who need same-day access workflows and outreach beyond the visit.
Job: deliver “simple, joyful, high-quality” primary care (company language) where geography — not insurance product design alone — is the barrier.
Why this is a live problem now
- Rural clinic closures and provider shortages are structural; software-only telehealth did not fix them.
- Value-based and impact capital (Citi Impact, foundations, Merkin) increasingly finance care delivery, not just SaaS sold to health systems.
- 8VC’s health/ops thesis fits clinics as the unit of deployment.
Why 8VC / Town Hall fit
| Investor | Fit (judgment) |
|---|---|
| 8VC | Lead continuity into Series D — underwriting multi-site clinical ops, not a seed story. |
| Town Hall Ventures | Healthcare services specialist co-lead. |
| Doerr / Merkin / foundations | Signal capital + outcomes networks; useful for rural political/operating cover. |
Likely founder rationale: keep 8VC as the venture voice; add Town Hall for healthcare operating depth; bring impact/strategic names for market expansion credibility.
Competitive map
| Player | Difference |
|---|---|
| Pure telehealth | Lower CapEx; weaker for exam-heavy primary care |
| Urban DPC / One Medical | Different geography and payer mix |
| Hospital outpatient | Broader specialty; often less same-day primary access |
Practical takeaways
- Founders: Rural care raises on panel size, visit access, and unit economics per clinic — show all three.
- Investors: Model provider recruiting as the hard constraint.
- Operators: Ask how tech “strengthens human connection” without becoming call-center medicine.
When not to
- Do not confuse Series D clinic rollups with asset-light SaaS multiples.
- Do not assume Southeast density transfers to every rural state equally (regulation, Medicaid mix).
- Total funding ~$103M is secondary aggregation (AlleyWatch) — prefer company disclosures for diligence.
Sources
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.
